NDAORALTABLET
Approved
Aug 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ACTONEL WITH CALCIUM is a copackaged oral combination therapy containing risedronate sodium (a bisphosphonate) and calcium carbonate for the treatment and prevention of osteoporosis in postmenopausal women. Risedronate works by inhibiting bone resorption, while the copackaged calcium provides supplemental mineral support essential for bone health. This combination addresses both the pharmacological need to slow bone loss and the nutritional requirement for adequate calcium intake.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), signaling a transition from growth to defensive positioning and potential team reductions or redeployment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ACTONEL WITH CALCIUM offers experience in lifecycle management and defensive marketing as the product approaches LOE; however, limited job openings (0 linked roles) indicate this is not a growth area for career expansion. Professionals on this team should prepare for potential portfolio transitions or pursue roles in generic/biosimilar divisions post-LOE.
Brand Manager
Worked on ACTONEL WITH CALCIUM (COPACKAGED) at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.